Therapeutic Potential of Qilianxiaopi Formula: Targeting ADAM17-Mediated Chronic Inflammation in Atrophic Gastritis

Therapeutic Potential of Qilianxiaopi Formula: Targeting ADAM17-Mediated Chronic Inflammation in Atrophic Gastritis

<b>Background</b>: Gastric cancer (GC) is a leading cause of mortality worldwide, particularly in China. Chronic atrophic gastritis (CAG) and intestinal metaplasia (IM) are recognized as precancerous conditions contributing to GC development. Qilianxiaopi formula (QLXP), a traditional Ch...

Full description

Saved in:
Bibliographic Details
Main Authors: Sijing Du, Tianxiang Wang, Zhiqiang Li, Ting Li, Zelong Miao, Yuling Chen, Songbiao Zhu, Wei Wei, Haiteng Deng
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Pharmaceuticals
Subjects:
chronic atrophic gastritis
Qilianxiaopi formula
network pharmacology
thermal proteome profiling
bio-layer interferometry
ADAM17
Online Access:https://www.mdpi.com/1424-8247/18/3/435
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1424-8247/18/3/435

Similar Items